Biopharmaceutical company developing therapeutics for orphan genetic diseases with a focus on neuromuscular disorders
Total raised: $78M
Investors 3
| Date | Name | Website |
| - | New Enterp... | nea.com |
| - | Idinvest P... | idinvest.c... |
| - | GIMV | gimv.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.07.2013 | IPO | $78M | - | idinvest.c... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 14.04.2015 | Duchenne M... | “These mutation-specific drugs... | - | - | medcitynew... |
| 02.07.2013 | VC-backed ... | Dutch biotechnology company Pr... | - | - | idinvest.c... |
| - | Duchenne M... | As a whole host of new Duchenn... | - | - | medcitynew... |